Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Background: For many patients, current treatments do not adequately resolve heartburn in nonerosive reflux disease (NERD). Objective: To compare vonoprazan and placebo with respect to the frequency and severity of heartburn in patients with NERD. Methods: This Phase III, double-blind, placebo-contro...
Main Authors: | Yoshikazu Kinoshita, MD, PhD, Yuuichi Sakurai, MPharm, Madoka Shiino, MPharm, Kentaro Kudou, MS, Akira Nishimura, BSc, MBA, Takuya Miyagi, MD, PhD, Katsuhiko Iwakiri, MD, PhD, Eiji Umegaki, MD, PhD, Kiyoshi Ashida, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-01-01
|
Series: | Current Therapeutic Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0011393X1630100X |
Similar Items
-
Correlation of narrow band imaging endoscopy and histopathology in the diagnosis of nonerosive reflux disease
by: P Arul, et al.
Published: (2015-01-01) -
Some issues of the diagnosis and treatment of gastroesophageal reflux disease
by: V G Avdeev
Published: (2015-10-01) -
An open-label pilot study to explore usefulness of Homoeopathic treatment in nonerosive gastroesophageal reflux disease
by: Renu Mittal, et al.
Published: (2016-01-01) -
In Vitro and In Vivo Rat Model Assessments of the Effects of Vonoprazan on the Pharmacokinetics of Venlafaxine
by: Chen F, et al.
Published: (2020-11-01) -
Features of the clinical course of gastroesophageal reflux disease associated with obesity
by: Andreeva E.l.
Published: (2018-03-01)